Axogen annual gross profit
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Axogen Gross Profit Growth & History (AXGN)
Axogen's gross profit was $167.4M for fiscal 2025.
View full Axogen company overviewAxogen annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $167.4M | $25.4M | +17.87% |
| 2024 | 2024-12-31 | $142.0M | $20.1M | +16.50% |
| 2023 | 2023-12-31 | $121.9M | $13.1M | +12.00% |
| 2022 | 2022-12-31 | $108.8M | $4.4M | +4.20% |
| 2021 | 2021-12-31 | $104.4M | $13.7M | +15.11% |
| 2020 | 2020-12-31 | $90.7M | $1.4M | +1.52% |
| 2019 | 2019-12-31 | $89.4M | $18.3M | +25.84% |
| 2018 | 2018-12-31 | $71.0M | $19.9M | +38.93% |
| 2017 | 2017-12-31 | $51.1M | $16.5M | +47.56% |
| 2016 | 2016-12-31 | $34.6M | $12.2M | +54.08% |
| 2015 | 2015-12-31 | $22.5M | $9.1M | +68.09% |
| 2014 | 2014-12-31 | $13.4M | $4.9M | +57.22% |
| 2013 | 2013-12-31 | $8.5M | $2.8M | +48.48% |
| 2012 | 2012-12-31 | $5.7M | $3.3M | +136.48% |
| 2011 | 2011-12-31 | $2.4M | $797,417 | +49.06% |
| 2010 | 2010-12-31 | $1.6M | — | — |
Axogen quarterly gross profit
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $50.7M | $8.7M | +20.60% |
| Q1 2026 | 2026-03-31 | $46.2M | $11.3M | +32.22% |
| Q4 2025 | 2025-12-31 | $44.4M | $6.8M | +18.19% |
| Q3 2025 | 2025-09-30 | $46.0M | $9.6M | +26.22% |
| Q2 2025 | 2025-06-30 | $42.0M | $6.7M | +18.88% |
| Q1 2025 | 2025-03-31 | $34.9M | $2.3M | +7.09% |
| Q4 2024 | 2024-12-31 | $37.6M | $5.6M | +17.34% |
| Q3 2024 | 2024-09-30 | $36.4M | $4.7M | +14.93% |
| Q2 2024 | 2024-06-30 | $35.3M | $5.7M | +19.20% |
| Q1 2024 | 2024-03-31 | $32.6M | $4.1M | +14.49% |
| Q4 2023 | 2023-12-31 | $32.0M | $7.6M | +31.26% |
| Q3 2023 | 2023-09-30 | $31.7M | $921,000 | +2.99% |
| Q2 2023 | 2023-06-30 | $29.7M | $1.5M | +5.26% |
| Q1 2023 | 2023-03-31 | $28.5M | $3.0M | +11.90% |
| Q4 2022 | 2022-12-31 | $24.4M | −$1.7M | −6.56% |
| Q3 2022 | 2022-09-30 | $30.8M | $4.8M | +18.56% |
| Q2 2022 | 2022-06-30 | $28.2M | $1.7M | +6.35% |
| Q1 2022 | 2022-03-31 | $25.5M | −$404,000 | −1.56% |
| Q4 2021 | 2021-12-31 | $26.1M | −$923,000 | −3.41% |
| Q3 2021 | 2021-09-30 | $26.0M | −$1.8M | −6.37% |
| Q2 2021 | 2021-06-30 | $26.5M | $10.0M | +60.43% |
| Q1 2021 | 2021-03-31 | $25.9M | $6.4M | +33.02% |
| Q4 2020 | 2020-12-31 | $27.0M | $3.8M | +16.11% |
| Q3 2020 | 2020-09-30 | $27.7M | $3.7M | +15.29% |
| Q2 2020 | 2020-06-30 | $16.5M | −$5.9M | −26.48% |
| Q1 2020 | 2020-03-31 | $19.4M | −$126,000 | −0.64% |
| Q4 2019 | 2019-12-31 | $23.3M | $3.5M | +17.62% |
| Q3 2019 | 2019-09-30 | $24.1M | $4.9M | +25.31% |
| Q2 2019 | 2019-06-30 | $22.5M | $5.0M | +28.49% |
| Q1 2019 | 2019-03-31 | $19.6M | $5.0M | +34.54% |
| Q4 2018 | 2018-12-31 | $19.8M | $5.4M | +37.86% |
| Q3 2018 | 2018-09-30 | $19.2M | $5.7M | +41.75% |
| Q2 2018 | 2018-06-30 | $17.5M | $4.6M | +35.58% |
| Q1 2018 | 2018-03-31 | $14.5M | $4.2M | +40.89% |
| Q4 2017 | 2017-12-31 | $14.4M | $4.8M | +49.88% |
| Q3 2017 | 2017-09-30 | $13.5M | $4.0M | +42.43% |
| Q2 2017 | 2017-06-30 | $12.9M | $4.0M | +45.70% |
| Q1 2017 | 2017-03-31 | $10.3M | $3.6M | +53.96% |
| Q4 2016 | 2016-12-31 | $9.6M | $3.2M | +49.82% |
| Q3 2016 | 2016-09-30 | $9.5M | $2.8M | +41.00% |
| Q2 2016 | 2016-06-30 | $8.8M | $3.5M | +64.53% |
| Q1 2016 | 2016-03-31 | $6.7M | $2.7M | +68.99% |
| Q4 2015 | 2015-12-31 | $6.4M | $2.6M | +66.64% |
| Q3 2015 | 2015-09-30 | $6.7M | $3.0M | +78.62% |
| Q2 2015 | 2015-06-30 | $5.4M | $2.1M | +61.66% |
| Q1 2015 | 2015-03-31 | $4.0M | $1.5M | +62.84% |
| Q4 2014 | 2014-12-31 | $3.8M | $1.4M | +60.63% |
| Q3 2014 | 2014-09-30 | $3.8M | $1.5M | +63.62% |
| Q2 2014 | 2014-06-30 | $3.3M | $1.1M | +49.23% |
| Q1 2014 | 2014-03-31 | $2.4M | $854,267 | +53.98% |
| Q4 2013 | 2013-12-31 | $2.4M | $822,263 | +52.50% |
| Q3 2013 | 2013-09-30 | $2.3M | $868,636 | +60.38% |
| Q2 2013 | 2013-06-30 | $2.2M | $718,400 | +47.56% |
| Q1 2013 | 2013-03-31 | $1.6M | $368,417 | +30.34% |
| Q4 2012 | 2012-12-31 | $1.6M | $737,831 | +89.05% |
| Q3 2012 | 2012-09-30 | $1.4M | $1.4M | +13685.11% |
| Q2 2012 | 2012-06-30 | $1.5M | $709,404 | +88.54% |
| Q1 2012 | 2012-03-31 | $1.2M | $431,488 | +55.12% |
| Q4 2011 | 2011-12-31 | $828,514 | — | — |
| Q3 2011 | 2011-09-30 | $10,436 | −$629,535 | −98.37% |
| Q2 2011 | 2011-06-30 | $801,192 | — | — |
| Q1 2011 | 2011-03-31 | $782,784 | — | — |
| Q3 2010 | 2010-09-30 | $639,971 | — | — |
Axogen gross profit trends
Over the last five fiscal years, Axogen's gross profit increased from $90.7M to $167.4M, a change of $76.6M. The latest reported quarter, Q2 2026, shows $50.7M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Axogen source filings ↗Community posts
Axogen pairs a $200 million BioCircuit acquisition with a share offering
Axogen ($AXGN) agreed to acquire BioCircuit Technologies for $200 million in cash, adding the NerveTape platform for sutureless peripheral-nerve repair. The buyer expects the transaction to support revenue growth and improve adjusted EBITDA ...